Filana Therapeutics, Inc. (NASDAQ: FLNA) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT FILANA THERAPEUTICS, INC.

Filana Therapeutics, Inc. (NASDAQ: FLNA)
Listen to this Section


$1.33
-0.0750 ( -5.36% ) 222.9K

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A.

Market Data


Open $1.33
Previous Close $1.40
Volume 222.9K
Market Cap $67.63M
Day Range $1.32 - $1.47
52 Week Range $1.16 - $2.27
Shares Outstanding 48.31M
Change % -5.36%
Net Change ▼ -0.0750
Insider Ownership N/A
Exchange NASDAQ
Sector
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2000
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


No data available for selected period.

Latest News


× Before browsing our site, please accept our cookies policy